About Tomas Kiselak
Tomas Kiselak is a director and 10% owner at Korsana Biosciences.
Form D filings name Tomas Kiselak as a director at Interius BioTherapeutics and Zenas BioPharma.
Tomas Kiselak reports to the SEC as a director or major shareholder of 10 public companies, including Apogee Therapeutics (APGE), Crescent Biopharma (CBIO) and Viridian Therapeutics (VRDN).
Tomas Kiselak first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Tomas Kiselak in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tomas Kiselak works with at each company, as listed on that company's latest Form D.